Publications by authors named "T Shalem"
Objectives: The impact of disease burden extends beyond pediatric inflammatory bowel disease (IBD) patients to include their parents. Previous studies, predating the biologic era, have highlighted parental concerns about potential side effects associated with IBD medications. However, there is a notable gap in the literature regarding parents' perceptions of clinical studies involving pediatric IBD patients.
View Article and Find Full Text PDFUnlabelled: Oral immunotherapy (OIT) may induce eosinophilic esophagitis (EoE). Proton pump inhibitors (PPIs) are an effective treatment for EoE. However, the effect of PPI treatment is not well established in patients with EoE induced by OIT.
View Article and Find Full Text PDFPast studies have reported differences between pediatric and adult celiac disease patients. We aimed to compare factors associated with adherence to a gluten-free diet between these groups. An anonymous online questionnaire was sent via the Israeli Celiac Association and social networks to celiac patients.
View Article and Find Full Text PDFArticle Synopsis
- A survey of Israeli gastroenterologists revealed that 62% prescribed biosimilar drugs in the past year, mostly to patients who were new to biologics.
- Most gastroenterologists (75%) believe that biosimilars have the same effectiveness as brand-name drugs but show resistance to switching patients, especially those in remission for over two years and pregnant women.
- Overall, while there is a general confidence in biosimilars' safety and efficacy, many physicians prefer to prescribe brand-name medications like adalimumab.